Osteoporosis drugs on every 2026 New Jersey Part D plan
Pick a drug class, or type the drugs you want to check, and see which of the 12 stand-alone Part D plans in New Jersey cover each one, on what tier, and with what restrictions.
- Covered
- Covered, needs prior authorization (PA) or step therapy (ST)
- Not on the formulary
- QL 60/30d = quantity limit, 60 units per 30 days
12 plans, cheapest premium first. Scroll sideways for all of them →
| Drug | Humana Basic Rx Plan$4.40/moS5884-131 | Wellcare Value Script$22.80/moS4802-139 | Wellcare Classic$28.20/moS4802-078 | Humana Value Rx Plan$35.60/moS5884-183 | HealthSpring Extra Rx$59.90/moS5617-354 | Horizon Medicare Blue Rx Standard$72.30/moS5993-001 | AARP Medicare Rx Saver from UHC$77.40/moS5921-349 | SilverScript Choice$97.40/moS5601-008 | HealthSpring Assurance Rx$109.30/moS5617-018 | Humana Premier Rx Plan$111.90/moS5884-150 | AARP Medicare Rx Preferred from UHC$118.90/moS5921-386 | Horizon Medicare Blue Rx Enhanced$139.10/moS5993-003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| alendronategeneric Fosamax | Tier 2$1.00QL 30/30d | Tier 1$0.00QL 30/30d | Tier 1$0.00QL 30/30d | Tier 1$0.00QL 30/30d | Tier 1$0.00 | Tier 1$0.00QL 120/30d | Tier 2$8.00QL 30/30d | Tier 1$0.00 | Tier 1$0.00QL 30/30d | Tier 1$0.00QL 30/30d | Tier 1$5.00QL 30/30d | Tier 1$0.00QL 120/30d |
| risedronategeneric Actonel | Not covered | Tier 2$3.00QL 1/30d | Not covered | Not covered | Not covered | Not covered | Not covered | Tier 433%QL 1/28d | Not covered | Not covered | Not covered | Tier 320%QL 1/28d |
| ibandronategeneric Boniva | Tier 325%QL 1/28d | Tier 2$3.00QL 1/30d | Tier 325%QL 1/30d | Tier 319%QL 1/28d | Tier 316%QL 1/28d | Tier 2$3.00QL 1/28d | Tier 317%QL 1/28d | Tier 433%QL 1/30d | Tier 320%QL 1/28d | Tier 3$45.00QL 1/28d | Tier 315%QL 1/28d | Tier 2$6.00QL 1/28d |
| Proliadenosumab | Tier 432%QL 1/180d | Not covered | Not covered | Tier 432%QL 1/180d | Tier 430%QL 1/180d | Not covered | Not covered | Not covered | Tier 427%QL 1/180d | Tier 450%QL 1/180d | Not covered | Not covered |
| denosumab biosimilarsJubbonti, Ospomyv and others | Not covered | Tier 440%QL 1/180d | Tier 429%QL 1/180d | Not covered | Not covered | Tier 4PA45% | Tier 436%QL 1/180d | Tier 433%QL 1/180d | Not covered | Not covered | Tier 433%QL 1/180d | Tier 4PA45% |
| Evenityromosozumab | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered |
| Forteoteriparatide | Tier 5PA25%QL 2.24/28d | Not covered | Not covered | Tier 5PA26%QL 2.24/28d | Not covered | Not covered | Not covered | Not covered | Not covered | Tier 5PA33%QL 2.24/28d | Not covered | Not covered |
| teriparatidegeneric Forteo | Not covered | Tier 5PA25%QL 2.48/28d | Tier 5PA25%QL 2.48/28d | Not covered | Tier 5PA25%QL 2.48/28d | Not covered | Tier 5PA25%QL 2.48/28d | Tier 5PA25% | Tier 5PA25%QL 2.48/28d | Not covered | Tier 5PA31%QL 2.48/28d | Tier 5PA30% |
| Tymlosabaloparatide | Not covered | Not covered | Not covered | Not covered | Not covered | Tier 5PA25% | Not covered | Tier 5PA25% | Not covered | Not covered | Tier 5PA31%QL 1.56/30d | Tier 5PA30% |
Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.